Acute Responses to Manipulating Dietary Carbohydrate Content on Free-living Physical Activity Energy Expenditure

May 2, 2022 updated by: Javier Gonzalez, University of Bath

Dietary sugar and carbohydrate intakes will be manipulated for 3 days in a randomised crossover design. All food will be provided. Free-living physical activity energy expenditure will be measured using combined heart rate and accelerometry. Metabolic and appetite/mood responses to 3 days on each diet will be measured.

Each participant will undergo 3 days of each diet:

  1. Moderate sugar - reflecting the composition of a typical European diet
  2. Low sugar - similar macronutrient composition of a typical European diet but with <5% energy intake from free sugars (as per government guidelines)
  3. Low carbohydrate - low carbohydrate diet with <5% energy intake from sugar and <8% energy intake from carbohydrate, replacing carbohydrate energy with fat

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Guidelines calling for dietary free sugars to be reduced have been formulated from evidence that diets high in sugar are associated with high energy intake. In theory, by reducing the intake of sugars, calorie surplus will be reduced and energy balance will be maintained. However, when referring to interventions/behaviours that influence energy balance, both sides of the energy balance equation need to be considered. Alterations in nutrients may influence aspects of energy expenditure, not solely energy intake, and this may have implications for the efficacy of guidelines seeking to influence energy intake.

It is important to consider energy expenditure in the context of health. The most variable component of energy expenditure between individuals is physical activity energy expenditure (PAEE), which varies from ~600-2100 kcal per day in men of a similar demographic. Current guidelines do not regard the effect that changing dietary sugar might have on PAEE and therefore total energy expenditure.

Furthermore, there is increasing interest in restricting overall carbohydrate intake to treat metabolic disease or achieve ketogenesis. Very little is known about nutrition-physical activity interactions with this type of intervention.

This study will prescribe 3 diets to healthy males for 3 days in a randomised crossover design, where each participant will consume each of the diets. All food will be prepared and provided by the study team. The diets are as follows:

  1. Moderate sugar - reflecting the composition of a typical European diet
  2. Low sugar - similar macronutrient composition of a typical European diet but with <5% energy intake from free sugars (as per government guidelines)
  3. Low carbohydrate - low carbohydrate diet with <5% energy intake from sugar and <8% energy intake from carbohydrate, replacing carbohydrate energy with fat

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Somerset
      • Bath, Somerset, United Kingdom, BA2 7AY
        • University of Bath

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Body mass index 18.5-29.9 kg∙m-2
  • Age 18-65 years
  • Male
  • Able and willing to provide informed consent and safely comply with study procedures
  • No anticipated changes in physical activity during the study (e.g. holidays)

Exclusion Criteria:

  • Any reported condition or behaviour deemed either to pose undue personal risk to the participant or introduce bias
  • Any diagnosed metabolic disease (e.g. type 1 or type 2 diabetes)•Any reported use of substances which may pose undue personal risk to the participants or introduce bias into the experiment
  • Lifestyle not conforming to standard sleep-wake cycle (e.g. shift worker)
  • Any reported recent (<6 months) change in body mass (±3%)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: MODSUG
Diet consisting of 50% carbohydrate (20% sugar), 15% protein, 35% fat
Macronutrient composition (specifically type and/or amount of carbohydrate) is manipulated
Experimental: LOWSUG
Diet consisting of 50% carbohydrate (<5% sugar), 15% protein, 35% fat
Macronutrient composition (specifically type and/or amount of carbohydrate) is manipulated
Experimental: LOWCHO
Diet consisting of <8% carbohydrate (<5% sugar), 15% protein, >77% fat
Macronutrient composition (specifically type and/or amount of carbohydrate) is manipulated

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity energy expenditure (kj/day or kcal/day)
Time Frame: 3 days
Physical activity energy expenditure measured using individually-calibrated combined heart rate and accelerometry (kj/day or kcal/day)
3 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time spent in different physical activity intensities (MET categories) (minutes)
Time Frame: 3 days
Time spent in different physical activity intensities (MET categories) (minutes) using individually-calibrated combined heart rate and accelerometry
3 days
Energy expended in different physical activity intensities (MET categories) (kJ/day or kcal/day)
Time Frame: 3 days
Energy expended in different physical activity intensities (MET categories) (kJ/day or kcal/day) using individually-calibrated combined heart rate and accelerometry
3 days
Energy expended in the postprandial period (kJ or kcal)
Time Frame: 3 days
Energy expended in the postprandial period (kJ or kcal) measured using individually-calibrated combined heart rate and accelerometry
3 days
Fasting blood glucose concentrations
Time Frame: 3 days
Measures of blood glucose concentrations pre- and post-intervention.
3 days
Fasting blood insulin concentrations
Time Frame: 3 days
Measures of blood insulin concentrations pre- and post-intervention.
3 days
Fasting blood triglyceride concentrations
Time Frame: 3 days
Measures of blood triglyceride concentrations pre- and post-intervention.
3 days
Fasting blood non-esterified fatty acid concentrations
Time Frame: 3 days
Measures of blood non-esterified fatty acid concentrations pre- and post-intervention.
3 days
Fasting blood lactate concentrations
Time Frame: 3 days
Measures of blood lactate concentrations pre- and post-intervention.
3 days
Fasting blood beta-hydroxybutyrate concentrations
Time Frame: 3 days
Measures of blood beta-hydroxybutyrate concentrations pre- and post-intervention.
3 days
Fasting blood leptin concentrations
Time Frame: 3 days
Measures of blood leptin concentrations pre- and post-intervention.
3 days
Fasting blood fibroblast growth factor-21 concentrations
Time Frame: 3 days
Measures of blood fibroblast growth factor-21 concentrations pre- and post-intervention.
3 days
Fasting blood total cholesterol concentrations
Time Frame: 3 days
Measures of blood total cholesterol concentrations pre- and post-intervention.
3 days
Fasting blood high density lipoprotein concentrations
Time Frame: 3 days
Measures of blood high density lipoprotein concentrations pre- and post-intervention.
3 days
Fasting blood low density lipoprotein concentrations
Time Frame: 3 days
Measures of blood low density lipoprotein concentrations pre- and post-intervention.
3 days
Food preference ratings
Time Frame: 3 days
Food preference ratings determined by computer task measured pre- and post-intervention
3 days
Subjective appetite and mood ratings
Time Frame: 3 days
Measured by 0-100 mm visual analogue scales measured pre- and post-intervention
3 days
Blood pressure
Time Frame: 3 days
Blood pressure using an automated sphygmomanometer pre- and post-intervention
3 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Actual)

July 1, 2021

Study Completion (Actual)

September 1, 2021

Study Registration Dates

First Submitted

April 10, 2019

First Submitted That Met QC Criteria

April 13, 2019

First Posted (Actual)

April 17, 2019

Study Record Updates

Last Update Posted (Actual)

May 4, 2022

Last Update Submitted That Met QC Criteria

May 2, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • EP 17/18 219

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Diet

Subscribe